Literature DB >> 29042436

Wilms tumor protein-dependent transcription of VEGF receptor 2 and hypoxia regulate expression of the testis-promoting gene Sox9 in murine embryonic gonads.

Karin M Kirschner1, Lina K Sciesielski2, Katharina Krueger1, Holger Scholz3.   

Abstract

Wilms tumor protein 1 (WT1) has been implicated in the control of several genes in sexual development, but its function in gonad formation is still unclear. Here, we report that WT1 stimulates expression of Kdr, the gene encoding VEGF receptor 2, in murine embryonic gonads. We found that WT1 and KDR are co-expressed in Sertoli cells of the testes and somatic cells of embryonic ovaries. Vivo-morpholino-mediated WT1 knockdown decreased Kdr transcripts in cultured embryonic gonads at multiple developmental stages. Furthermore, WT1 bound to the Kdr promoter in the chromatin of embryonic testes and ovaries. Forced expression of the WT1(-KTS) isoform, which functions as a transcription factor, increased KDR mRNA levels, whereas the WT1(+KTS) isoform, which acts presumably on the post-transcriptional level, did not. ChIP indicated that WT1(-KTS), but not WT1(+KTS), binds to the KDR promoter. Treatment with the KDR tyrosine kinase inhibitor SU1498 or the KDR ligand VEGFA revealed that KDR signaling represses the testis-promoting gene Sox9 in embryonic XX gonads. WT1 knockdown abrogated the stimulatory effect of SU1498-mediated KDR inhibition on Sox9 expression. Exposure to 1% O2 to mimic the low-oxygen conditions in the embryo increased Vegfa expression but did not affect Sox9 mRNA levels in gonadal explants. However, incubation in 1% O2 in the presence of SU1498 significantly reduced Sox9 transcripts in cultured testes and increased Sox9 levels in ovaries. These findings demonstrate that both the local oxygen environment and WT1, which enhances KDR expression, contribute to sex-specific Sox9 expression in developing murine gonads.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  chromatin immunoprecipitation (ChiP); development; gene regulation; gene silencing; gene transcription; hypoxia; immunohistochemistry; ovary; testis; transcription factor

Mesh:

Substances:

Year:  2017        PMID: 29042436      PMCID: PMC5724013          DOI: 10.1074/jbc.M117.816751

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

2.  Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?

Authors:  H Kikuchi; A Takata; Y Akasaka; R Fukuzawa; H Yoneyama; Y Kurosawa; M Honda; Y Kamiyama; J Hata
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

3.  KDR-LacZ-expressing cells are involved in ovarian and testis-specific vascular development, suggesting a role for VEGFA in the regulation of this vasculature.

Authors:  Rebecca C Bott; Debra T Clopton; Anna M Fuller; Ryann M McFee; Ningxia Lu; Renee M McFee; Andrea S Cupp
Journal:  Cell Tissue Res       Date:  2010-09-17       Impact factor: 5.249

4.  Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.

Authors:  Julie Hanson; Jacquelyn Gorman; Jennifer Reese; Gail Fraizer
Journal:  Front Biosci       Date:  2007-01-01

5.  The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.

Authors:  A A Morrison; J P Venables; G Dellaire; M R Ladomery
Journal:  Biochem Cell Biol       Date:  2006-10       Impact factor: 3.626

6.  Functional analysis of Sox8 and Sox9 during sex determination in the mouse.

Authors:  Marie-Christine Chaboissier; Akio Kobayashi; Valerie I P Vidal; Susanne Lützkendorf; Henk J G van de Kant; Michael Wegner; Dirk G de Rooij; Richard R Behringer; Andreas Schedl
Journal:  Development       Date:  2004-03-31       Impact factor: 6.868

7.  WT1-mediated gene regulation in early urogenital ridge development.

Authors:  J Klattig; R Sierig; D Kruspe; M S Makki; C Englert
Journal:  Sex Dev       Date:  2007       Impact factor: 1.824

8.  Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.

Authors:  S H Larsson; J P Charlieu; K Miyagawa; D Engelkamp; M Rassoulzadegan; A Ross; F Cuzin; V van Heyningen; N D Hastie
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

9.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

Authors:  C Englert; X Hou; S Maheswaran; P Bennett; C Ngwu; G G Re; A J Garvin; M R Rosner; D A Haber
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

10.  Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues.

Authors:  S Mundlos; J Pelletier; A Darveau; M Bachmann; A Winterpacht; B Zabel
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  3 in total

1.  Implications of the Wilms' Tumor Suppressor Wt1 in Cardiomyocyte Differentiation.

Authors:  Nicole Wagner; Marina Ninkov; Ana Vukolic; Günseli Cubukcuoglu Deniz; Minoo Rassoulzadegan; Jean-François Michiels; Kay-Dietrich Wagner
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

2.  Involvement of DHH and GLI1 in adrenocortical autograft regeneration in rats.

Authors:  Nae Takizawa; Susumu Tanaka; Souichi Oe; Taro Koike; Takashi Yoshida; Yukie Hirahara; Tadashi Matsuda; Hisao Yamada
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

3.  Wt1 haploinsufficiency induces browning of epididymal fat and alleviates metabolic dysfunction in mice on high-fat diet.

Authors:  Karin M Kirschner; Anna Foryst-Ludwig; Sabrina Gohlke; Chen Li; Roberto E Flores; Ulrich Kintscher; Michael Schupp; Tim J Schulz; Holger Scholz
Journal:  Diabetologia       Date:  2021-11-30       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.